Risk of invasive fungal infection on treatment - CLL Support
Risk of invasive fungal infection on treatment
You need to be a member of this community to see this post.
Read more about...
27 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Update for UK FLAIR Study Participants who have come to the end of 6 years of Ibrutininb treatment.
Many patients were fortunate to receive Ibrutinib as their first treatment in the UK FLAIR study...
Long-term effects of ibrutinib on blood pressure in patients with CLL
It seems that the hypertension ( HTN) seen by patients being treated with Ibrutinib continues to...
Possible Risk of Fungal Infection with Ibrutinib
It's just one case, but probably worth keeping in mind if you develop the symptoms.
"In...
Factors Identified for Risk of Second Cancer in CLL Following BTK Inhibition
There was hope that non-chemo CLL treatments would avoid the increased risk of subsequent secondary...
Clinical trial results & reviews of new treatments for CLL written in easy to understand terms
Anyone interested in reading a weekly update of the latest breaking news for CLL may want to sign...
Related Posts
Ibrutinib vs FCR: does order of therapy matter?- Optimal Treatment Combinations in the Management of CLL/SLL Jeff Sharman, MD Provided by Clinical Care Options, LLC
- Thoughts on CLL treatment and watch and wait
- Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus Venetoclax
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
